Cue Biopharma, Inc. — Director's Dealing 2021

Oct 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cue Biopharma, Inc. (CUE)
CIK: 0001645460
Period of Report: 2021-10-03

Reporting Person: Suri Anish (PRESIDENT AND CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-03	Common Stock	M	33334	—	Acquired	108172	Direct
2021-10-06	Common Stock	F	14134	$12.97	Disposed	94038	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-03	Restricted Stock Units	$	M	33334	Disposed		Common Stock (33334)	Direct

Footnotes

F1: Represents shares of common stock received upon vesting of a restricted stock unit award.

F2: Each restricted stock unit award represents a contingent right to receive one share of common stock.

F3: On October 3, 2019, the reporting person was granted 100,000 restricted stock units, scheduled to vest in three equal annual installments beginning on October 3, 2019.